← Open Payments lookup

ALEXANDER LEMMER: Open Payments

NPI 1104168681 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,759 in 51 payments from 13 companies in 2025. Trend: 2023 $292 · 2024 $648 · 2025 $3,759

Speaker / faculty: $2,025Food & beverage: $1,734
CompanyPaymentsAmount
Boston Scientific Corporation15$2,338
Madrigal Pharmaceuticals7$344
Amgen Inc.10$321
Gilead Sciences, Inc.8$206
OrganOx LTD1$154
AstraZeneca Pharmaceuticals LP1$117
Novo Nordisk Inc1$89
TriSalus Life Sciences, Inc.2$52
Ethicon US, LLC1$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$40

Products named: General - Therapies, REZDIFFRA, EXALT Model D, UPLIZNA, METRA, TRINAV INFUSION SYSTEM, VISTASEAL, XIFAXAN.

Industry payments across GA — which companies pay providers there.